Lyon,
FRANCE

Strasbourg,
FRANCERockville, MD
USA

test

X

test

Integrated to
ABL manufacturing network in June 2018

Modern facility built in 2013,
opening inspection in 2014

Number of employees:

61

Inspection history

ABL is inspected routinely by the French National Agency for the Safety of Medicines and Health (ANSM), approved and GMP licensed in accordance with EMA (available from EudraLex).

Last ANSM (French National Agency for the Safety of Medicines and Health) inspections:
No critical observation reported

INSPECTION & DATEFEEDBACK
JULY 2020
Routine inspection		No critical observation
JULY 2018
GMP License transfer to ABL Europe		Gene Therapy products added
MARCH 2019
SEPTEMBRE 2017
Routine inspection		No critical observation

Read more

317 Avenue Jean Jaurès
69007 Lyon FRANCE

Phone: +33 3 88 55 10 00

Email: contact@ableurope.com

200L
Single use technology

Suite 1: Grade A / B / C.
Suspended & adherent (microcarriers)

200L
Single use technology

Suite 2: Grade A / C.
Suspended & adherent (microcarriers)

200L
Single use technology

Suite 3: Grade A / C.
Suspended & adherent (microcarriers)
Operational in Q2 2023

Process development & analytical laboratories

Up to
500 vials
per batch

DP manual filling in grade A / B

Contact us